MDX-1342, a fully human monoclonal antibody (HuMAb), targets the CD19 membrane receptor with high specificity and affinity. It exhibits antibody-dependent cellular cytotoxicity (ADCC) and is utilized in researching B-lymphocyte malignancies and autoimmune diseases [1].
CAS Number:
[1646327-65-2]
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted
